Your browser doesn't support javascript.
loading
Cyclophosphamide-induced cardiotoxicity at conditioning for allogeneic hematopoietic stem cell transplantation would occur among the patients treated with 120 mg/kg or less.
Marumo, Atsushi; Omori, Ikuko; Tara, Shuhei; Otsuka, Yuki; Konuma, Ryosuke; Adachi, Hiroto; Wada, Atsushi; Kishida, Yuya; Konishi, Tatsuya; Nagata, Akihito; Yamada, Yuta; Nagata, Ryohei; Noguchi, Yuma; Toya, Takashi; Igarashi, Aiko; Najima, Yuho; Kobayashi, Takeshi; Yamaguchi, Hiroki; Inokuchi, Koiti; Sakamaki, Hisashi; Ohashi, Kazuteru; Doki, Noriko.
Affiliation
  • Marumo A; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
  • Omori I; Department of Hematology, Nippon Medical School, Tokyo, Japan.
  • Tara S; Department of Hematology, Nippon Medical School, Tokyo, Japan.
  • Otsuka Y; Division of Cardiovascular Intensive Care Unit, Nippon Medical School, Tokyo, Japan.
  • Konuma R; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
  • Adachi H; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
  • Wada A; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
  • Kishida Y; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
  • Konishi T; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
  • Nagata A; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
  • Yamada Y; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
  • Nagata R; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
  • Noguchi Y; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
  • Toya T; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
  • Igarashi A; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
  • Najima Y; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
  • Kobayashi T; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
  • Yamaguchi H; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
  • Inokuchi K; Department of Hematology, Nippon Medical School, Tokyo, Japan.
  • Sakamaki H; Department of Hematology, Nippon Medical School, Tokyo, Japan.
  • Ohashi K; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
  • Doki N; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
Asia Pac J Clin Oncol ; 18(5): e507-e514, 2022 Oct.
Article in En | MEDLINE | ID: mdl-35289086

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / Graft vs Host Disease / Heart Failure Type of study: Etiology_studies / Risk_factors_studies / Screening_studies Limits: Humans Language: En Journal: Asia Pac J Clin Oncol Journal subject: NEOPLASIAS Year: 2022 Document type: Article Affiliation country: Japón

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / Graft vs Host Disease / Heart Failure Type of study: Etiology_studies / Risk_factors_studies / Screening_studies Limits: Humans Language: En Journal: Asia Pac J Clin Oncol Journal subject: NEOPLASIAS Year: 2022 Document type: Article Affiliation country: Japón